Breaking News Instant updates and real-time market news.

THC

Tenet

$16.39

-0.76 (-4.43%)

, ATKR

Atkore

$18.43

0.11 (0.60%)

15:35
09/13/17
09/13
15:35
09/13/17
15:35

Tenet not attending upcoming Deutsche Bank conference

According to Deutsche Bank's website, Tenet Healthcare (THC) will not be participating in the bank's 25th Annual Leveraged Finance Conference that is taking place between October 2-4. Atkore International (ATKR), General Cable (BGC), Eldorado Gold (EGO), Westmoreland Coal (WLB), Tronox (TROX), Univar (UNVR), IHS Markit (INFO), Sunoco (SUN), Martin Midstream (MMLP), Navient (NAVI), Alliance HealthCare Services (AIQ), Mallinckrodt (MNK), and Broadcom (AVGO) are among other companies that have also cancelled their attendance. Reference Link

THC

Tenet

$16.39

-0.76 (-4.43%)

ATKR

Atkore

$18.43

0.11 (0.60%)

BGC

General Cable

$18.65

0.75 (4.19%)

EGO

Eldorado Gold

$2.28

0.31 (15.74%)

WLB

Westmoreland

$2.31

0.07 (3.13%)

TROX

Tronox

$23.19

-0.05 (-0.22%)

UNVR

Univar

$28.21

-0.145 (-0.51%)

INFO

IHS Markit

$48.30

0.35 (0.73%)

SUN

Sunoco

$31.77

0.135 (0.43%)

MMLP

Martin Midstream Partners

NAVI

Navient

$14.42

0.29 (2.05%)

AIQ

Alliance HealthCare

MNK

Mallinckrodt

$35.57

-0.88 (-2.41%)

AVGO

Broadcom

$247.14

-0.6 (-0.24%)

  • 13

    Sep

  • 13

    Sep

  • 26

    Sep

  • 02

    Oct

  • 16

    May

THC Tenet
$16.39

-0.76 (-4.43%)

09/06/17
CANT
09/06/17
NO CHANGE
CANT
Overweight
Irma threat a risk for HCA, public hospital peers, says Cantor
Cantor Fitzgerald analyst Joseph France noted that HCA Holdings (HCA), Community Health (CYH), LifePoint (LPNT), Tenet (THC) and Envision Healthcare (EVHC) all have business in Florida and Texas and are all down today on the potential threat from Hurricane Irma and the impact from Hurricane Harvey last week. HCA reports nearly half of its beds are in Florida and Texas while Envision has said in the past that more than half of its anesthesia business and about half of its legacy ER business is in those two states, noted France, who adds that Community Health, LifePoint and Tenet are less exposed to those states. The analyst keeps an Overweight rating on HCA shares.
08/28/17
JEFF
08/28/17
NO CHANGE
JEFF
Buy
HCA has 11% of its beds in Harvey impacted areas, says Jefferies
Jefferies analyst Brian Tanquilut points out that HCA Holdings (HCA) has 11% of its beds in areas impacted by severe weather from Hurricane Harvey. The analyst expects the hurricane to cause a "notable disruption," specifically for hospitals, physician offices, surgery centers, and labs. Investors are likely to take a long-term view of Hurricane Harvey, however, as it is a one-time issue and thus excluded from operating and financial results, Tanquilut tells investors in a research note. He sees both Tenet (THC) and Community Health (CYH) being minimally impacted from the storm. Envision Healthcare's (EVHC) AmSurg segment has three ambulatory surgery centers in the impacted markets, while Surgery Partners (SGRY) has only one facility in Houston, the analyst adds.
09/01/17
MSCO
09/01/17
NO CHANGE
Target $15
MSCO
Equal Weight
Tenet turnaround may take several quarters to take root, says Morgan Stanley
Morgan Stanley analyst Zack Sopcak said Tenet's search for a new CEO and board changes are likely to drive short-term share gains, but he remains on the sidelines, citing the stock's 36% run-up in the two weeks prior to last night's announcement and his belief that it could be several quarters before a turnaround takes root. Sopcak keeps an Equal Weight rating and $15 price target on Tenet shares.
09/01/17
JPMS
09/01/17
NO CHANGE
JPMS
Neutral
JPMorgan cautions against chasing shares of Tenet
JPMorgan analyst Gary Taylor expects shares of Tenet to move higher today after the company announced CEO Trevor Fetter is stepping down and that it adopted a poison pill a day in advance of the Glenview standstill agreement expiration. In a research note titled "Less than Meets the Eye?," Taylor cautions investors against chasing the shares. There is limited ability now for activists to compel change, and a base-case sum-of-the-parts valuation analysis yields an $8-$19 share price, Taylor tells investors. He keeps a Neutral rating on Tenet.
ATKR Atkore
$18.43

0.11 (0.60%)

08/09/17
FBCO
08/09/17
UPGRADE
Target $22
FBCO
Outperform
Atkore upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Julian Mitchell upgraded Atkore to Outperform from Neutral following its sharp share price drop upon the release of Q3 figures. The analyst thinks the concerns that he had highlighted in his initiation report in mid-2016 are now fully factored in. Mitchell also lowered his price target on the shares to $22 from $26 due to his lowered forecasts, reflecting a weaker non-res demand outlook and increased raw material headwinds.
08/09/17
WELS
08/09/17
NO CHANGE
WELS
Atkore weakness overdone, says Wells Fargo
Wells Fargo says that the 22% plunge in Atkore's stock was overdone. The firm thinks the decline prices in further downturns in the company's fiscal 2018 earnings outlook relative to its sector. It believes that the stock now "more than" prices in all upcoming risks, and it expects the shares to increase "modestly" in the nearer term. Wells keeps an Outperform rating on the shares.
BGC General Cable
$18.65

0.75 (4.19%)

12/01/16
KING
12/01/16
INITIATION
KING
Neutral
General Cable initiated with a Neutral at CL King
EGO Eldorado Gold
$2.28

0.31 (15.74%)

07/31/17
SCOT
07/31/17
DOWNGRADE
SCOT
Sector Perform
Eldorado Gold downgraded to Sector Perform from Outperform at Scotiabank
09/12/17
MACQ
09/12/17
DOWNGRADE
MACQ
Neutral
Eldorado Gold downgraded to Neutral from Outperform at Macquarie
Macquarie analyst downgraded Eldorado Gold to Neutral following the company's decision to suspend all investment in Greece by September 22 due to the government's continuing delay and opposition to development. The analyst cut his price target to C$3.00 from C$5.00 but said downside is limited.
07/31/17
07/31/17
DOWNGRADE
Target $2.4

Underperform
Eldorado Gold downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Anita Soni downgraded Eldorado Gold to Underperform from Neutral due to continued set-backs in Greece, another re-assessment of timelines and capital plans in Greece in light of on-going challenges, and prolonged negative free cash flow until 2021 if Skouries is built, or 2018 positive free cash flow of about $100M but a reduced CS NAV estimate if Skouries is suspended. The analyst also lowered her price target on the shares to $2.40 from $3.25.
07/31/17
FBCO
07/31/17
DOWNGRADE
FBCO
Underperform
Eldorado Gold downgraded to Underperform from Neutral at Credit Suisse
WLB Westmoreland
$2.31

0.07 (3.13%)

08/04/17
BMOC
08/04/17
DOWNGRADE
BMOC
Market Perform
Westmoreland downgraded after Q2 results at BMO Capital
As noted earlier, BMO Capital downgraded Westmoreland to Market Perform from Outperform. Analyst David Gagliano downgraded the stock after the company missed Q2 expectations and cut its full-year EBITDA guidance. The analyst says that ,given the company's high debt load, " even small reductions in EBITDA cuts deeply into the equity component of the enterprise value." Target to $5 from $18.
11/04/16
GHSC
11/04/16
INITIATION
Target $20
GHSC
Buy
Westmoreland initiated with a Buy at Seaport Global
Seaport analyst Mark Levin initiated Westmoreland with a Buy and a $20 price target.
08/03/17
BMOC
08/03/17
DOWNGRADE
BMOC
Market Perform
Westmoreland downgraded to Market Perform from Outperform at BMO Capital
TROX Tronox
$23.19

-0.05 (-0.22%)

07/05/17
07/05/17
NO CHANGE

Tronox increases soda ash prices
Tronox Limited announced that, effective immediately or as contract terms permit, Tronox Alkali will increase soda ash prices by $6.00 per short ton for all grades of soda ash. The increase applies to both bulk and packaged products. Tronox Alkali freight policy remains unchanged with all agreements on a freight collect basis. On customer request, Tronox will prepay all transportation charges - inclusive of fuel surcharges - and add these charges to the invoice with a $1.00 per short ton service charge. Tronox Alkali's current energy surcharge program remains in effect.
UNVR Univar
$28.21

-0.145 (-0.51%)

02/13/17
EVER
02/13/17
INITIATION
Target $35
EVER
Buy
Univar initiated with a Buy at Evercore ISI
Evercore ISI analyst Laurent Favre initiated coverage of the chemicals sector, starting Univar with a Buy rating and $35 target.
02/23/17
FBCO
02/23/17
NO CHANGE
Target $36
FBCO
Outperform
Univar price target raised to $36 from $31 at Credit Suisse
Credit Suisse analyst Andrew Buscaglia raised his price target for Univar to $36 from $31 after the company put together a "solid Q4" that showed EBITDA growth for the first time in seven quarters. The analyst reiterates an Outperform rating on the shares.
07/06/17
BREN
07/06/17
INITIATION
Target $124
BREN
Sell
Univar initiated with a Sell at Berenberg
Berenberg initiated Univar with a Sell and a $124 price target.
08/31/17
FBCO
08/31/17
NO CHANGE
Target $36
FBCO
Outperform
Hurricane Harvey to impact Univar, says Credit Suisse
Credit Suisse analyst Andrew Buscaglia notes that Univar announced it expects Hurricane Harvey will hurt Q3 adjusted EBITDA by $10M-$25M and is also likely to affect Q4, although it's too early to quantify. The analyst reiterated an Outperform rating on the shares but lowered his price target on the stock to $36 from $39.
INFO IHS Markit
$48.30

0.35 (0.73%)

06/16/17
DBAB
06/16/17
NO CHANGE
Target $52
DBAB
Buy
Deutsche sees path for IHS Markit hitting $55-$60 per share
Deutsche Bank analyst Kevin McVeigh introduced an analysis "with a line of sight" to $55-$60 per share for IHS Markit. The analyst upped his price target for the stock to $52 from $50. Mid-single-digit organic growth and margin expansion could drive positive estimate revisions, McVeigh tells investors in a research note titled "MARKing a case for $55-$60 stock." The analyst sees a path to mid-40% EBITDA margins and keeps a Buy rating on IHS.
09/16/16
BARD
09/16/16
UPGRADE
Target $41
BARD
Outperform
IHS Markit upgraded to Outperform at Baird
As reported previously, Baird analyst Jeffrey Meuler upgraded IHS Markit to Outperform from Neutral. The analyst views it as an attractively valued portfolio of high quality information solutions businesses and a provider of mission-critical solutions with the potential to be an attractive acquisition/capital deployment program. Meuler raised his price target to $41 from $39 on IHS Markit shares.
01/20/17
PIPR
01/20/17
NO CHANGE
Target $48
PIPR
Overweight
IHS Markit price target raised to $48 from $43 at Piper Jaffray
Piper Jaffray analyst Peter Appert raised his price target for IHS Markit to $48 after meetings with management reinforced his confidence in the company's near-term growth outlook. The analyst views the company's growth targets as "aggressive but achievable." He calls IHS Markit his top information services GARP pick for 2017.
03/29/17
DBAB
03/29/17
NO CHANGE
Target $50
DBAB
Buy
IHS Markit price target raised to $50 from $44 at Deutsche Bank
Deutsche Bank analyst Kevin McVeigh raised his price target for IHS Markit to $50 and keeps a Buy rating on the name following the company's Q1 results. The analyst views the 2017 guidance as conservative and expects the stock to benefit when the company presents it forward strategy at its investor day on April 26. Investors should become more comfortable in IHS Markit's ability to drive 4%-6% long-term organic revenue growth, McVeigh tells investors in a post-earnings research note.
SUN Sunoco
$31.77

0.135 (0.43%)

07/10/17
MZHO
07/10/17
DOWNGRADE
MZHO
Underperform
Sunoco downgraded to Underperform from Neutral at Mizuho
05/01/17
05/01/17
DOWNGRADE
Target $27

Neutral
Sunoco Logistics downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst John Edwards downgraded Sunoco Logistics (SXL) to Neutral from Outperform following the announced merger with Energy Transfer Equity (ETE). The analyst notes that post-merger, Sunoco Logistics becomes the largest MLP under the Energy Transfer umbrella and owns about 44% stake in Sunoco (SUN). He also lowered his price target on Sunoco Logistics' shares to $27 from $31.
07/13/17
DBAB
07/13/17
UPGRADE
DBAB
Buy
Sunoco upgraded to Buy from Hold at Deutsche Bank
04/25/17
SBSH
04/25/17
UPGRADE
Target $29
SBSH
Neutral
Sunoco upgraded to Neutral from Sell at Citi
Citi analyst Faisel Khan upgraded Sunoco to Neutral citing the company's agreement to sell 1,110 of its retail convenience stores to the holding company parent of 7-11. The analyst is positive on the sale and upped his price target for the shares to $29 from $22.
MMLP Martin Midstream Partners

04/28/17
STFL
04/28/17
DOWNGRADE
STFL
Hold
Martin Midstream Partners downgraded to Hold from Buy at Stifel
12/06/16
STFL
12/06/16
UPGRADE
STFL
Buy
Martin Midstream Partners upgraded to Buy from Hold at Stifel
04/28/17
STFL
04/28/17
DOWNGRADE
STFL
Hold
Martin Midstream Partners downgraded based on valuation at Stifel
As noted earlier, Stifel downgraded Martin Midstream to Hold from Buy. Analyst Selman Akyol downgraded the stock based on valuation.
12/06/16
12/06/16
UPGRADE
Target $19

Buy
Martin Midstream Partners upgraded to Buy at Stifel
As previously reported, Stifel analyst Selman Akyol upgraded Martin Midstream Partners to Buy from Hold, citing the roughly 19% decline in the stock since its earnings report on October 27. While the marine segment has been challenged, Martin Midstream's other business segments have been relatively stable and not much has changed since late October to warrant the weakness, said Aykol, who keeps a $19 price target on the stock.
NAVI Navient
$14.42

0.29 (2.05%)

09/08/17
FBCO
09/08/17
UPGRADE
Target $16.5
FBCO
Outperform
Navient upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Moshe Orenbuch upgraded Navient to Outperform saying shares are "too cheap" after a 20% selloff year-to-date and maintained a $16.50 price target. The analyst said has several positives including strong cash flows should lead to substantial repurchases, government loan margin supported by improved 3/1 month libor spread, reduced regulatory risk, and a call option on tax reform.
01/30/17
WEDB
01/30/17
INITIATION
Target $16.5
WEDB
Neutral
Navient initiated with a Neutral at Wedbush
Wedbush initiated Navient with a Neutral and a $16.50 price target.
09/05/17
COMP
09/05/17
UPGRADE
Target $16.5
COMP
Buy
Navient upgraded to Buy from Neutral at Compass Point
Compass Point upgraded Navient to Buy from Neutral with a $16.50 price target. Analyst Michael Tarkan believes the regulatory environment for student lenders/servicers will become more benign over the next few years following the Department of Educations announcement that it intends to end two information sharing agreements with the CFPB related to oversight of federal loans. The analyst expects Navient to be a beneficiary of reduced regulation and said the recent pullback in shares provides an favorable entry point.
09/05/17
COMP
09/05/17
UPGRADE
COMP
Buy
Navient upgraded to Buy from Neutral at Compass Point
AIQ Alliance HealthCare

MNK Mallinckrodt
$35.57

-0.88 (-2.41%)

09/06/17
09/06/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. HP Enterprise (HPE) downgraded to Underperform from Neutral at BofA/Merrill with analyst Wamsi Mohan citing fiscal 2018 headwinds that include increased investment, a competitive pricing environment, and higher commodity costs. 2. Marathon Petroleum (MPC) downgraded to Market Perform from Outperform at Wells Fargo with analyst Roger Read saying he now expects the incentive distribution rights buyout may be at the lower end of the prior 15-20 times range. 3. Verifone (PAY) downgraded to Neutral from Buy at Northcoast with analyst Keith Housum saying he has reduced confidence in the company's ability to grow revenues and increase profitability given the delay in reaching the point of sale market with its new Carbon and Engage platform compared to initial expectations. 4. Mallinckrodt (MNK) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger saying he believes yesterday's unfavorable district court ruling in Mallinckrodt's suit against Praxair (PX) has increased the risk of an Inomax generic potentially as soon as October 2018, compared to his prior expectation of 2031. 5. BHP Billiton (BHP) downgraded to Underperform from Neutral at Exane BNP Paribas. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/17
MZHO
09/13/17
DOWNGRADE
Target $40
MZHO
Neutral
Mallinckrodt downgraded to Neutral on competitive headwinds at Mizuho
As previously reported, Mizuho downgraded Mallinckrodt (MNK) to Neutral from Buy and slashed its price target to $40 from $70. Following the unexpectedly negative Inomax District Court decision. Analyst Irina Koffler said Mallinckrodt consists of a gradually declining generics portfolio, and a "basket" of branded assets that face some degree of competition and downside risks. Koffler lowered his Inomax forecast to reflect a second market entrant and sees risk to Arthar from any positive progress by competitor ANI Pharmaceuticals (ANIP).
09/13/17
09/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. ON Semiconductor (ON) downgraded to Neutral from Buy at Goldman Sachs with analyst Mark Delaney citing the stock's relative outperformance and lack of catalysts over the next year. 2. Nordstrom (JWN) downgraded to Hold from Accumulate at Gordon Haskett. 3. Mallinckrodt (MNK) downgraded to Neutral from Buy at Mizuho with analyst Irina Koffler saying Mallinckrodt consists of a gradually declining generics portfolio, and a "basket" of branded assets that face some degree of competition and downside risks. 4. Whiting Petroleum (WLL) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Drew Venker citing weak risk-reward relative to peers. 5. GasLog (GLOG) downgraded to Hold from Buy at DNB Markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/13/17
MZHO
09/13/17
DOWNGRADE
MZHO
Neutral
Mallinckrodt downgraded to Neutral from Buy at Mizuho
AVGO Broadcom
$247.14

-0.6 (-0.24%)

09/13/17
CHLM
09/13/17
NO CHANGE
CHLM
Iphone increasing band count positive for RF suppliers, says Craig-Hallum
Craig-Hallum analyst Tony Stoss notes that there are two new bands in the Apple (AAPL) iPhone 8/8 Plus /X in comparison to the iPhone 7. The analyst believes this is a positive for RF suppliers as increasing band count requires additional RF content per phone and believes total RF content is closer to $28 in the upcoming phones up from estimate of $26 for the iPhone 7. Stoss also believes RF suppliers are set up to benefit longer term as increasing band count, new technologies such as MIMO and CA will drive increased RF content per smartphone. The analyst reiterates a Buy rating on Skyworks (SWKS), Qorvo (QRVO) and Broadcom (AVGO).
09/13/17
COWN
09/13/17
NO CHANGE
COWN
Apple supply chain read-through indicates unit growth in Q4, says Cowen
Cowen analyst Karl Ackerman said Apple's (AAPL) presentation was largely in line with expectations, but his supply chain work indicates a significant increase in iPhone X units for the December quarter. Based on his checks, companies with the most "interesting" read-through include Micron (MU), Teradyne (TER), Broadcom (AVGO), Qorvo (QRVO), Skyworks, (SWKS), and Universal Display (OLED), he tells investors.
09/13/17
FBCO
09/13/17
NO CHANGE
FBCO
Apple launch mostly as expected, says Credit Suisse
Credit Suisse analyst John Pitzer notes that Apple (AAPL) has announced four product updates largely in-line with expectations, and points out that semi companies in his coverage universe with exposure to Apple include Broadcom (AVGO), Micron (MU) and Texas Instruments (TXN).
09/13/17
KEYB
09/13/17
NO CHANGE
KEYB
Apple new iPhone 8/X launch largely in-line with expectations, says KeyBanc
KeyBanc analyst John Vinh says that the incremental features and enhancements associated with the new Apple (AAPL) iPhones announced are largely in-line with expectations. The analyst points out that Apple announced three new phones, with key features including facial identification, removal of the home button on the iPhone X, wireless charging, and fast charging. Vihn sees the new phone launch as most positive for Broadcom (AVGO), Cypress Semiconductor (CY), Integrated Device (IDTI), and Skyworks (SWKS).

TODAY'S FREE FLY STORIES

GM

General Motors

$39.42

0.32 (0.82%)

11:43
09/23/17
09/23
11:43
09/23/17
11:43
Periodicals
GM to eliminate shift at Tennessee SUV plant on 'moderating' sales, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.25

0.19 (0.35%)

11:34
09/23/17
09/23
11:34
09/23/17
11:34
Periodicals
Wells Fargo hires law firm to prepare CEO for Senate appearance, Reuters says »

Wells Fargo has hired law…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 03

    Oct

  • 13

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

EADSY

Airbus

$23.06

-0.01 (-0.04%)

11:27
09/23/17
09/23
11:27
09/23/17
11:27
Periodicals
Airbus in talks to sell all or part of Premium Aerotec, Reuters says »

Airbus is said to be in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGX

Quest Diagnostics

$102.11

0.56 (0.55%)

11:06
09/23/17
09/23
11:06
09/23/17
11:06
Hot Stocks
Quest Diagnostics 'disappointed' with proposed PAMA 2018 Medicare payment rates »

Quest Diagnostics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

IRBT

iRobot

$76.14

-3.8 (-4.75%)

10:58
09/23/17
09/23
10:58
09/23/17
10:58
Periodicals
iRobot suffering after onslaught of SharkNinja cheaper models, Barron's says »

In a follow up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.